Skip to main content

Table 4 Rates of 30 days and 90 days side effects from the start of treatment

From: Treatment outcome and compliance to dose-intensified linac-based SBRT for unfavorable prostate tumors using a novel real-time organ-motion tracking

Genitourinary toxicity

Gastrointestinal toxicity

 

30 days

90 days

30 days

90 days

Grade

1

5 (38.6%)

5 (38.6%)

1 (7.7%)

2 (15.4%)

2

0 (0)

0 (0)

0 (0)

0 (0)

 ≥ 3

0 (0)

0 (0)

0 (0)

0 (0)